Avalyn Pharma Inc. Common Stock (AVLN) Financials
AVLN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 425.4 million | 27.1 million |
| March 31, 2026 | 135.7 million | 399.9 million |
| June 30, 2025 | ? | ? |
| March 31, 2025 | ? | ? |
AVLN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -26.3 million | 2.8 million |
| March 31, 2026 | -30.2 million | 1.2 million |
| June 30, 2025 | -20.7 million | 1.1 million |
| March 31, 2025 | -19.3 million | 543000 |
AVLN Net Income
No data available :(
AVLN Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 352.4 million | 14.8 million | 1.5 million |
| March 31, 2026 | 123.1 million | 14.8 million | 1.6 million |
| June 30, 2025 | - | - | - |
| March 31, 2025 | - | - | - |
AVLN Shares Outstanding
AVLN Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 269000 | 24.7 million | 6.5 million | - |
| March 31, 2026 | 318000 | 22.9 million | 5.0 million | - |
| June 30, 2025 | - | 17.9 million | 3.9 million | - |
| March 31, 2025 | 8000 | 15.3 million | 3.4 million | - |
AVLN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | 110000 |
| March 31, 2026 | - | - |
| June 30, 2025 | - | - |
| March 31, 2025 | - | - |
AVLN
Price: $33.57
52 week price:
Earnings Per Share: -2.33 USD
Exchange: NGM
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Market Capitalization: 1.7 billion